If you haven`t bought GILD on the Remdesivir approval:
Then analyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week, I would consider purchasing the 80usd strike price in the money Calls with an expiration date of 2024-1-19, for a premium of approximately $4.25. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.